Abstract
We analyzed outcomes of 102,985 SARS-CoV-2 confirmed cases of patients attending the IMSS (Mexican Institute for National Insurance) from January 2 to August 3, 2020. We calculated relative IFR by age group and gender and introduced the concept of adjusted lethalities, that can be used to project the burden of the disease for a population with different demographic characteristics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is part of the program "Building the Evidence on Protracted Forced Displacement: A Multi-Stakeholder Partnership". The program is funded by UK aid from the United Kingdom's Department for International Development (DFID), it is managed by the World Bank Group (WBG) and was established in partnership with the United Nations High Commissioner for Refugees (UNHCR). The scope of the program is to expand the global knowledge on forced displacement by funding quality research and disseminating results for the use of practitioners and policy makers. This work does not necessarily reflect the views of DFID, the WBG or UNHCR. This study had approval R-2020-601-07 by the Health Research Ethics Committee (601) of the IMSS.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study had approval R-2020-601-07 by the Health Research Ethics Committee (601) of the IMSS.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The previous version analyzed 34,686 patients. We updated the database and now we include the results for 102,985 patients.
Data Availability
The data set is only available to researchers of the IMSS for their analysis and exploration.
